Top Institutions in Addiction Psychiatry and Psychedelic Research
Institutions leading in this area typically conduct randomized controlled trials integrating psychedelic compounds with psychotherapy for substance use disorders, leveraging expertise in addiction psychiatry, clinical trial design, and neuropharmacology.
-
#1
Johns Hopkins University School of Medicine
Baltimore, MD
Pioneers in psychedelic-assisted therapy research with multiple landmark clinical trials on psilocybin for addiction and mental health disorders, including the referenced smoking cessation trial.
Key Differentiators
- Addiction Psychiatry
- Psychedelic Research
- Clinical Trials
-
#2
University of California, San Francisco (UCSF)
San Francisco, CA
Strong research programs in addiction psychiatry and clinical trials involving novel therapies for substance use disorders, including psychedelics.
Key Differentiators
- Addiction Medicine
- Psychiatry
- Clinical Neuroscience
-
#3
New York University (NYU) Langone Health
New York, NY
Notable for clinical research in psychedelic-assisted psychotherapy and addiction treatment, with ongoing studies on psilocybin and other psychedelics.
Key Differentiators
- Psychiatry
- Addiction Research
- Psychedelic Science
-
#4
Imperial College London
London, N/A
International leader in psychedelic neuroscience and clinical trials, with pioneering work on psilocybin's effects on brain function and addiction.
Key Differentiators
- Psychiatry
- Neuropsychopharmacology
- Psychedelic Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
